NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 11:35 PM

idiopathic

Type: Keyphrase

Name: idiopathic

First Reported 11/19/2009 - Updated 11/20/2009 - 5 Documents

Swissmedic grants marketing authorization for Amitiza

Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) ... [News-Medical.Net - 11/20/2009]

Entities: Swissmedic, Sucampo Pharmaceuticals, Inc, Switzerland, idiopathic

First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents

Albireo reports positive data from Phase Ib constipation trial

Swedish biotechnology company Albireo has completed a Phase Ib study showing a favorable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation.In addition, the data revealed appropriate efficacy signals in this patient ... [Individual.com - 11/20/2009]

Entities: Albireo, idiopathic, efficacy, Biotechnology

First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents

Body composition, ovarian function normal in women treated with GnRHa during childhood

Women treated with gonadotropin-releasing hormone analog treatment during childhood had normal BMI, bone mineral density, body composition and ovarian function during early adulthood. In addition, treatment with Gn-RH analog did not predispose this population ... [Endocrine Today - 11/20/2009]

Entities: idiopathic, Density, Greece

First Reported 22 hours ago - Updated 22 hours ago - 1 Documents

Sucampo Pharma Europe Receives Marketing Authorization for Amitiza(R) in Switzerland for Treatment of Chronic Idiopathic Constipation

BETHESDA, Md.--(BUSINESS WIRE)-- Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for AmitizaÂ® (lubiprostone) 24 microgram ... [BioSpace - 22 hours ago]

Entities: idiopathic, Switzerland, Sucampo Pharmaceuticals, Inc

First Reported 11/18/2009 - Updated 11/18/2009 - 2 Documents

AstraZeneca PLC

Albireo reports positive results from phase 1b study of A3309 for chronic idiopathic constipation

Swedish biotechnology company Albireo reported on Wednesday the completion of a phase 1b study of A3309 in patients with chronic idiopathic constipation.The study found a favourable tolerability and safety profile and the data also revealed appropriate ... [M2 - 11/18/2009]

Entities: Albireo, idiopathic, AstraZeneca PLC, efficacy

First Reported 10/23/2009 - Updated 10/23/2009 - 1 Documents

Questcor Announces Third Quarter 2009 Earnings Release Date and

UNION CITY, Calif., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that it will release financial results for the third quarter ended September 30, 2009 on Monday, November 2, 2009 after the market close. ... [GlobeNewswire via MSN Money - 10/23/2009]

Entities: Questcor Pharmaceuticals Incorporated, Multiple Sclerosis, Nephrotic Syndrome

First Reported 10/23/2009 - Updated 10/23/2009 - 1 Documents

Article Reviews Techniques for Idiopathic Clubfoot Correction

THURSDAY, Oct. 22 (HealthDay News) -- The techniques for performing the Ponseti and French functional methods of treating idiopathic clubfeet were the focus of an article in a supplement to the October Journal of Bone & Joint Surgery.Suzanne Steinman, ... [Modern Medicine - 10/23/2009]

Entities: idiopathic, Surgery, Malformation

First Reported 10/26/2009 - Updated 10/26/2009 - 1 Documents

The frustrations of FLUTD (Proceedings)

• Define the various etiologies that fall under the umbrella of FLUTD• Evaluate recent literature on the possible causes of idiopathic FLUTD• Discuss the appropriate diagnostic approach to pollakiuria/hematuria/stranguria in the cat• Outline the rationale ... [Thomson Veterinary Healthcare Communications - 10/26/2009]

Entities: etiology, idiopathic, neoplasia, Ureaplasma, urothelium

First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents (in Earth Science)

Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies

Some specimens composed of continuous carbonate apatite containing small amounts of proteins with mineral to protein ratio much higher than in bone, and other specimens contained scattered agglomerates of various sizes with similar composition (FTIR- ... [MDLinx - 10/27/2009]

Entities: Myopathy, Mineral, idiopathic

First Reported 10/27/2009 - Updated 10/27/2009 - 1 Documents (in Health)

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Genzyme commences patient enrollment in Genz-112638 phase 3 trialsGenzyme Corporation today announced that the company has begun enrollment in the first of two global...Novartis' Tasigna capsules meets primary endpoint in comparison trial with GleevecNovartis ... [News-Medical.Net - 10/27/2009]

Entities: Food and Drug Administration, Crohn's disease, Certolizumab Pegol

First Reported 11/02/2009 - Updated 11/02/2009 - 1 Documents

Multifactorial dysphagia: Diffuse idiopathic skeletal hyperostosis and eosinophilic esophagitis

1. Report Shows Shift in Starting Salaries for Physicians2. 2008 Exclusive Survey—Earnings: Good news for primary care income3. Medicare pay-for-reporting effort draws fire from frustrated doctors4. Debunking Myths in the US Healthcare System5. Appropriate ... [MDLinx - 11/02/2009]

Entities: esophagitis, dysphagia, idiopathic

First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents

Nerve growth factor level may be marker for neurogenic overactive bladder, interstitial cystitis

Mean NGF/Cr* levels: Patients vs. controlsPittsburgh—Nerve growth factor (NGF) levels in urine could prove a useful biomarker for interstitial cystitis/painful bladder syndrome (IC/PBS) and neurogenic overactive bladder.A study from the University of ... [Urology Times - 11/03/2009]

Entities: Public Broadcasting Service, William Beaumont, idiopathic, biomarker

Quotes

Ryuji Ueno, M D , Ph D , Ph D , Chairman and Chief Executive Officer of Sucampo PharmaceuticalsSucampo Pharmaceuticals Inc., said, "This approval gives doctors in Switzerland a safe, effective and long-term treatment option for their patients with chronic idiopathic constipation, a life-altering disorder. This decision further validates Amitiza's position as a safe and effective therapy for a chronic condition."

Sucampo Receives Marketing Authorization for Amitiza(R) in Switzerland for Treatment of Chronic... [Forbes.com - 11/19/2009]

...However, with vitreoretinal surgery, we can possibly prevent secondary ERM formation. Michels already stated in 1982 that, if: "[p]ortions of the ILM were seen in 67% of cases, surgical removal of portions of ILM did not seem to adversely affect the visual result. In fact, improved postoperative vision was obtained in 89% of eyes in which specimen fragments of the ILM were seen and vision improved postoperatively in only 64% of eyes in which ILM was not seen in the specimens … The low incidence of clinically apparent membrane recurrence was surprising since sizable fragments of ILM were present in 67% of specimens studied." 1

ILM Removal as a Prophylaxis of ERM Formation After Vitrectomy [Retinal Physician - 11/16/2009]

Current study results from the report, 'Screening for LRRK2 R1441 mutations in a cohort of PSP patients from Germany,' have been published. "Mutations in the leucine-rich repeat kinase gene (LRRK2) have been shown to be the most common genetic cause of both familial and sporadic Parkinson s disease. Patients harboring LRRK2 mutations develop late onset PD that in most cases cannot be clinically distinguished from idiopathic PD" scientists writing in the European Journal of Neurology report

Research from University of Tubingen, Hertie Institute for Clinical Brain Research provides new d ... [NewsRX - 11/15/2009]

"MetS was not associated with HIV-SN in this cohort of HIV-positive patients from multiple institutions (P = 0.72). However, two MetS components, diabetes mellitus type 2 and elevated TRG, increased the risk of HIV-SN. Specifically, elevated TRG (>150 mg/dl) conferred a 30% greater risk of HIV-SN, and self-reported diabetes mellitus type 2 conferred a 40% greater risk of HIV-SN. Both factors have been associated with idiopathic sensory neuropathy in HIV-uninfected populations [15]. Without HIV-uninfected controls, we cannot address whether the increased risks of HIV-SN from these MetS components produce an additive or interactive effect with HIV in causing sensory neuropathy."

Role of metabolic syndrome components in HIV-associated sensory neuropathy [National AIDS Treatment Advocacy Project - 11/02/2009]

More Content

sort by: Date \| Relevance
Sucampo Pharma Europe Receives Marketing Author... [BioSpace - 22 hours ago]
Body composition, ovarian function normal in wo... [Endocrine Today - 11/20/2009]
Albireo reports positive data from Phase Ib con... [Individual.com - 11/20/2009]
Swissmedic grants marketing authorization for A... [News-Medical.Net - 11/20/2009]
Sucampo Pharma (SCMP) Subsidiary Granted Market... [Street Insider - 11/19/2009]
Sucampo Receives Marketing Authorization for Am... [Forbes.com - 11/19/2009]
Sucampo Receives Marketing Authorization for Am... [Business Wire via MSN Money - 11/19/2009]
Sucampo Receives Marketing Authorization for Am... [Globe Investor - 11/19/2009]
Sucampo Receives Marketing Authorization for Am... [Yahoo! Canada - 11/19/2009]
Albireo reports positive results from phase 1b ... [M2 - 11/18/2009]
TopAbstracts in Urinary Incontinence 11/17/2009 [Doctors Guide - 11/18/2009]
Albireo Announces Positive Clinical Data on A33... [Yahoo! Canada - 11/18/2009]
ILM Removal as a Prophylaxis of ERM Formation A... [Retinal Physician - 11/16/2009]
Microincisional Vitrectomy Surgery for the Repa... [Retinal Physician - 11/16/2009]
Complete Spontaneous Resolution of Full-thickne... [Retinal Physician - 11/16/2009]
Research from University of Tubingen, Hertie In... [NewsRX - 11/15/2009]
Pulmonary Artery Hypertension (PAH): A Focus on... [Michigan Pharmacists Association - 11/15/2009]
Planet Resource Recovery Appoints Ph.D of Appli... [Market Wire via MSN Money - 11/11/2009]
Planet Resource Recovery Appoints Ph.D of Appli... [Stockwatch - 11/11/2009]
Radiological and clinical outcome of screw plac... [MDLinx - 11/11/2009]
Nonspecific therapy for uveitis [Thomson Veterinary Healthcare Communications - 11/11/2009]
Sitaxsentan Proves Effective Up to 6 Years for ... [Doctors Guide - 11/11/2009]
MUC5AC Mutations Play a Role in Pulmonary Fibrosis [Pulmonary Reviews - 11/11/2009]
Recurrence of hyperprolactinemia after withdraw... [Endocrine Today - 11/10/2009]
Extended PROLONG study follow-up supports conti... [MedWire News - 11/09/2009]
Man seen for progressive unilateral proptosis, ... [PCON SuperSite - 11/06/2009]
Sucampo Pharmaceuticals Invites Investors to Li... [Stockwatch - 11/06/2009]
Sucampo Pharmaceuticals Reports Financial Resul... [Genetic Engineering News - 11/05/2009]
College of Veterinary Medicine honors small-ani... [Media Newswire - 11/05/2009]
Bell's palsy before Bell: Evert Jan Thomassen &... [MDLinx - 11/05/2009]

Blogs

sort by: Date \| Relevance
CIGNA Is Still Up To Their Old Tricks. They're ... [Crooks and Liars - 10/03/2009] Amy Goodman interviews Stacie Ritter, whose twin daughters are being denied coverage by CIGNA for the followup care they need from the side-effects of cancer treatment: STACIE ...
Pharma Exec Convicted Of Pushing Alternative Us... [Clusterstock - 09/30/2009] Sometimes, drugs are prescribed and for conditions other than they were created for. That's legal, but drug-makers aren't allowed to market alternative use, known ...
FDA Calendar Updates: United Therapeutics, Roche [Biotech Sector and Stocks Analysis from Seeking ... - 07/30/2009] Mike Havrilla submits:Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was ...
Ford Vox: Want to Head Off a Twisted Future? Ge... [The Huffington Post Full Blog Feed - 06/09/2009] My reporting for Monday's Los Angeles Times (here and here) includes the statistic, derived from one study, that a solid majority of healthy people over ...
Ford Vox: Want To Prevent Back Problems? Get Up! [The Huffington Post Full Blog Feed - 06/01/2009] My reporting for Monday's Los Angeles Times includes the statistic, derived from one study, that a solid majority of healthy people over age 60 have scoliosis ...

Change Password

Log in to Silobreaker

Advanced Search Options

idiopathic